- Home
- RNR vs FMS Comparison
RNR vs FMS Comparison
Compare RNR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- FMS
- Stock Information
- Founded
- RNR 1993
- FMS 1996
- Country
- RNR Bermuda
- FMS Germany
- Employees
- RNR N/A
- FMS N/A
- Industry
- RNR Property-Casualty Insurers
- FMS Misc Health and Biotechnology Services
- Sector
- RNR Finance
- FMS Health Care
- Exchange
- RNR Nasdaq
- FMS Nasdaq
- Market Cap
- RNR 13.4B
- FMS 14.2B
- IPO Year
- RNR 1995
- FMS 1996
- Fundamental
- Price
- RNR $226.18
- FMS $23.09
- Analyst Decision
- RNR Hold
- FMS Hold
- Analyst Count
- RNR 11
- FMS 1
- Target Price
- RNR $279.90
- FMS $25.00
- AVG Volume (30 Days)
- RNR 554.5K
- FMS 234.7K
- Earning Date
- RNR 01-28-2025
- FMS 02-25-2025
- Dividend Yield
- RNR 0.71%
- FMS 2.75%
- EPS Growth
- RNR N/A
- FMS 46.47
- EPS
- RNR 35.21
- FMS 2.50
- Revenue
- RNR $11,771,224,000.00
- FMS $21,457,738,113.00
- Revenue This Year
- RNR N/A
- FMS $0.03
- Revenue Next Year
- RNR $4.25
- FMS $4.40
- P/E Ratio
- RNR $6.41
- FMS $18.46
- Revenue Growth
- RNR 28.28
- FMS N/A
- 52 Week Low
- RNR $208.98
- FMS $17.93
- 52 Week High
- RNR $300.00
- FMS $25.25
- Technical
- Relative Strength Index (RSI)
- RNR 33.63
- FMS 39.25
- Support Level
- RNR $228.66
- FMS $22.86
- Resistance Level
- RNR $233.76
- FMS $23.73
- Average True Range (ATR)
- RNR 4.81
- FMS 0.26
- MACD
- RNR -0.35
- FMS -0.22
- Stochastic Oscillator
- RNR 5.43
- FMS 12.38
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.